These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28601524)

  • 1. Rifampin Stability and Solution Concentration Enhancement Through Amorphous Solid Dispersion in Cellulose ω-Carboxyalkanoate Matrices.
    Arca HÇ; Mosquera-Giraldo LI; Pereira JM; Sriranganathan N; Taylor LS; Edgar KJ
    J Pharm Sci; 2018 Jan; 107(1):127-138. PubMed ID: 28601524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
    Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
    Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.
    Pereira JM; Mejia-Ariza R; Ilevbare GA; McGettigan HE; Sriranganathan N; Taylor LS; Davis RM; Edgar KJ
    Mol Pharm; 2013 Dec; 10(12):4640-53. PubMed ID: 24116899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellulose-based amorphous solid dispersions enhance rifapentine delivery characteristics in vitro.
    Winslow CJ; Nichols BLB; Novo DC; Mosquera-Giraldo LI; Taylor LS; Edgar KJ; Neilson AP
    Carbohydr Polym; 2018 Feb; 182():149-158. PubMed ID: 29279109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
    Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability.
    Li B; Konecke S; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):2033-40. PubMed ID: 23399255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-property evaluation of cellulose ω-carboxyesters for amorphous solid dispersions.
    Liu H; Ilevbare GA; Cherniawski BP; Ritchie ET; Taylor LS; Edgar KJ
    Carbohydr Polym; 2014 Jan; 100():116-25. PubMed ID: 24188845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
    Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro.
    Gilley AD; Arca HC; Nichols BLB; Mosquera-Giraldo LI; Taylor LS; Edgar KJ; Neilson AP
    Carbohydr Polym; 2017 Feb; 157():86-93. PubMed ID: 27988001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pairwise polymer blends for oral drug delivery.
    Marks JA; Wegiel LA; Taylor LS; Edgar KJ
    J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer.
    Marks JA; Nichols BLB; Mosquera-Giraldo LI; T Yazdi S; Taylor LS; Edgar KJ
    Mol Pharm; 2024 Sep; 21(9):4589-4602. PubMed ID: 39088435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine.
    Sarode AL; Malekar SA; Cote C; Worthen DR
    Carbohydr Polym; 2014 Nov; 112():512-9. PubMed ID: 25129775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
    Singh H; Bhandari R; Kaur IP
    Int J Pharm; 2013 Mar; 446(1-2):106-11. PubMed ID: 23410991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer.
    Bellini RG; Guimarães AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA
    J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified rifampin nanoparticles: Increased solubility with slow release Rate.
    Farnia P; Velayati AA; Mollaei S; Ghanavi J
    Int J Mycobacteriol; 2017; 6(2):171-176. PubMed ID: 28559520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan.
    Chella N; Tadikonda R
    Drug Dev Ind Pharm; 2015 Jun; 41(6):888-97. PubMed ID: 24796274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very fast dissolving acid carboxymethylcellulose-rifampicin matrix: Development and solid-state characterization.
    Luciani-Giacobbe LC; Ramírez-Rigo MV; Garro-Linck Y; Monti GA; Manzo RH; Olivera ME
    Eur J Pharm Sci; 2017 Jan; 96():398-410. PubMed ID: 27721041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation, characterization and pH dependence of rifampicin: heptakis(2,6-di-O-methyl)-β-cyclodextrin complexes.
    Angiolini L; Agnes M; Cohen B; Yannakopoulou K; Douhal A
    Int J Pharm; 2017 Oct; 531(2):668-675. PubMed ID: 28596140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.